Jocil Analyst Review May 2026
- May 22, 2026
- Posted by: Kunal Singla
- Category: News
This Jocil analyst review for May 2026 covers the key data investors need for JOCIL at its current price of Rs 498. Jocil (NSE: JOCIL) is a specialty chemicals company with a market capitalisation of approximately Rs 600 crore, manufacturing oleochemicals, fatty acids, and soap noodles from vegetable oils. The analyst consensus target of Rs 620 implies meaningful upside, and this Jocil analyst review examines technical levels, business performance, valuation, and key risks for JOCIL through FY27.
Click Here – Get Free Investment Predictions
Jocil Company Snapshot May 2026
Jocil’s fatty acids, glycerine, and soap noodles from natural vegetable oil feedstock serve soap makers, cosmetic companies, and industrial chemical buyers. The table below summarises the key data referenced in this Jocil analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | JOCIL |
| Sector | Specialty Chemicals – Fatty Acids |
| CMP (May 2026) | Rs 498 |
| 52 Week High | Rs 780 |
| 52 Week Low | Rs 428 |
| Market Cap | Rs 600 Crore |
| Trailing P/E | 15x |
| Analyst Consensus Target | Rs 620 |
| Bull Case Target | Rs 768 |
| Bear Case Target | Rs 435 |
Analyst Insight in This Jocil Analyst Review
Associate Director Kunal Singla suggests watching Jocil closely in May 2026. At Rs 498, Kunal Singla flags Specialty Chemicals – Fatty Acids sector dynamics as the primary driver for JOCIL’s near-term price action. He notes support in the Rs 436.56 to Rs 473.10 zone and flags a sustained close above Rs 527.88 as a positive signal. Kunal Singla’s perspective adds professional analysis to this Jocil analyst review and is not a buy recommendation.
Technical Analysis in This Jocil Analyst Review
At Rs 498, JOCIL is trading within its 52-week band of Rs 428 to Rs 780. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 436.56 to Rs 473.10 band while resistance is seen in the Rs 527.88 to Rs 559.00 zone. A sustained move above Rs 527.88 could open the path toward the analyst consensus target of Rs 620 as identified in this Jocil analyst review.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 436.56 to Rs 473.10 – investors tracking this Jocil analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for JOCIL.
- Resistance Zone: Rs 527.88 to Rs 559.00 – a sustained close above Rs 527.88 would be a positive breakout signal worth flagging in this Jocil analyst review.
- Medium-Term Target: The analyst consensus of Rs 620 represents the base-case upside scenario in this Jocil analyst review.
Business Segment Analysis
Fatty Acids and Oleochemicals Manufacturing
This is the primary revenue and margin driver for Jocil, directly supporting the earnings trajectory toward the consensus target of Rs 620.
Soap Noodles and Glycerine Products
This segment adds scale and diversification to Jocil’s business model and is a meaningful EPS contributor through FY27 and FY28.
Industrial Chemicals and Derivatives
This represents the medium-term growth frontier for Jocil and a key re-rating catalyst for the stock over the next 12 to 24 months.
Valuation in This Jocil Analyst Review
At Rs 498, Jocil trades at a trailing P/E of 15x. This Jocil analyst review presents three scenarios: a bull case of Rs 768 on strong earnings delivery, a base case of Rs 620 at analyst consensus, and a bear case of Rs 435 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Jocil analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 768 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 620 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 435 | Earnings miss or macro headwinds |
Trade Outlook for Jocil
Based on the technical and fundamental analysis in this Jocil analyst review, investors might watch JOCIL near the support zone of Rs 436.56 to Rs 473.10 for potential opportunities. A flag above Rs 527.88 could suggest improving momentum toward Rs 620. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for Jocil in FY27
A well-rounded Jocil analyst review must assess downside risks. Key risks for Jocil include a macro slowdown affecting Specialty Chemicals – Fatty Acids sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in JOCIL.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Jocil Analyst Review Verdict for 2026
This Jocil analyst review concludes that at Rs 498, JOCIL offers a defined risk-reward with a consensus target of Rs 620. The 52-week range of Rs 428 to Rs 780 provides context on the current entry point. Use this Jocil analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on JOCIL.
Frequently Asked Questions: Jocil Analyst Review 2026
What is the analyst target for Jocil in 2026?
The analyst consensus target is Rs 620, with a bull case of Rs 768 and a bear case of Rs 435. This Jocil analyst review recommends monitoring Q1 FY27 earnings for confirmation.
Is Jocil a good investment at Rs 498?
At Rs 498 with a P/E of 15x and a consensus target of Rs 620, this Jocil analyst review is constructive for medium to long-term investors in the Specialty Chemicals – Fatty Acids sector. Always consult a SEBI-registered advisor before investing.
What is Jocil’s 52-week high and low?
The 52-week high is Rs 780 and the 52-week low is Rs 428. At Rs 498, JOCIL is positioned within this range as noted in this Jocil analyst review.
What are the key risks for Jocil?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Specialty Chemicals – Fatty Acids sector as assessed in this Jocil analyst review.
Where can I track live data for Jocil?
Track Jocil’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Jocil analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
